Hello
We are noticing an uptick in our ADR rates for our patients receiving Flebogamma 10%. We are looking for institutions to share your infusion practices for IVIG. What is your institution’s preferred product? What rate of infusion and progression protocol do you follow?
Thanks!
Bridget Gegorski, Pharm.D.
Medication Safety Officer
University Hospitals Office: 216-983-1307
11100 Euclid Ave Fax: 216-844-3052
Cleveland, Ohio 44106 Mail Stop: WRN 5006
Bridget.Gegorski@UHHospitals.org